FOLH1 and prostate adenocarcinoma: Sweat et al. analyzed 232 patients with node-positive prostatic adenocarcinoma and noted that PSMA expression is significantly greater in prostate adenocarcinoma and lymph node metastases compared to benign prostatic tissue [16].